Intravenous Iron Therapy for Postpartum Anemia (Hemoglobin ≈ 9 g/dL)

Recommendation and Dosing

• Administer a single total‑dose infusion of 1000 mg intravenous iron (ferric derisomaltose, ferric carboxymaltose, or low‑molecular‑weight iron dextran) diluted in 100–250 mL normal saline over 15–60 minutes; oral iron supplementation should not be added. [1][2]

Choice of Formulation

• Ferric derisomaltose (FDI) – 1000 mg in 100 mL saline over 15–60 min; it is the only FDA‑labeled product for a total‑dose infusion and the first IV iron shown to reduce cardiovascular mortality in heart‑failure trials. 1
• Ferric carboxymaltose (FCM) – 1000 mg in 100–250 mL saline over 15–60 min; requires monitoring of serum phosphorus because of a risk of treatment‑emergent hypophosphatemia. 2
• Low‑molecular‑weight iron dextran (LMWID) – 1000 mg in 250 mL saline over 60 min; safety of a single 1000‑mg infusion is supported by multiple studies; infusion should be started slowly with observation during the first 5 minutes or a 25‑mg test dose per FDA labeling. 2

Monitoring and Follow‑Up

• Post‑infusion laboratory testing – obtain a complete blood count and iron studies (ferritin, transferrin saturation) 4–8 weeks after the infusion; earlier testing yields falsely elevated values due to circulating iron. 1
• Hemoglobin response – expect an increase of 1–2 g/dL within 4–8 weeks; a rise of <1 g/dL should prompt evaluation for ongoing blood loss or other causes of anemia. 1
• Ferritin target – aim for a ferritin level ≥ 50 ng/mL in the absence of inflammation. 1
• Clinical reassessment – re‑evaluate symptoms and hemoglobin at 4–8 weeks; if the response is adequate and no further losses are identified, a single total‑dose infusion is sufficient. 1
• Inadequate response – when hemoglobin rises <1 g/dL, investigate persistent bleeding (e.g., heavy menstrual bleeding) and consider repeat dosing if ongoing loss is confirmed. [1][4]

Safety Considerations & Pitfalls

• Do not check iron parameters within 4 weeks of the infusion, as results are misleadingly high. 1
• Do not use multiple small doses of iron sucrose for postpartum anemia; this regimen requires 4–7 visits, whereas single‑dose formulations achieve repletion in one visit. [1][2]

Note: All statements are derived from evidence published in the American Journal of Hematology* (2024) and reflect the strength of evidence reported in the source articles (primarily randomized controlled trials and systematic reviews).